会议专题

PIK3CA Mutation in Resected Small Cell Lung Cancer

Objectives: To know phosphatidylinositol3-kinase catalytic α (PIK3CA) mutation in small cell lung cancer (SCLC).Materials and Methods: Reverse transcription polymerase chain reaction (RT-PCR) and direct sequencing technology was used to detect PIK3CA mutation of 14 cases of retrospectively collected SCLC patients who received surgical treatment in ZhejiangCancerHospitalfrom 2002 to 2010.Results: Our current research revealed that no mutations were found in exons 9, 20 of the PIK3CA gene.The nucleotide change A1634C (E545A) of exon 9 was pseudogene-positive because the mutation disappeared by near duplicate.Conclusion: The incidence of PIK3CA mutation is low in SCLC patients, and the pseudogene-positive is prone to occur in exon 9 of PIK3CA mutation in human cancers.

韩娜 程巧鸳 陈波 蔡菊芬 王晓稼 楼彩金 覃晶 叶魏武 雷蕾 卢红阳

浙江省肿瘤医院肿瘤内科 浙江省食品药品检验研究院

国内会议

第八届中国肿瘤内科大会、第三届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2014年学术年会

北京

英文

629-629

2014-07-02(万方平台首次上网日期,不代表论文的发表时间)